|
[1] Bai Bing, Chadwick M Hales, Ping-Chung Chen. U1 small
nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease[J]. Proceedings
of the National Academy of Sciences of the United States of America, 2015, 110(41):
16562-16566.
[2] Sandrine Andrieu, Sophie Gillette, Karine Amouyal, et al. Association
of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive
treatments in a population of women aged 75 years and older from the EPIDOS study[J]. J
Gerontology Series A: Biological Sciences and Medical Sciences, 2014, 8(4): 55-61.
[3] 宋昕, 洪羽蓉, 胡秋莹. 阿尔茨海默症发病原因及机制的研究进展[J]. 临床和实验医学杂志, 2015, (10):91-93.
[4] 左萍萍. β淀粉样肽代谢与阿尔茨海默症[J]. 标记免疫分析与临床, 2001, 8(1):34-37.
[5] 干伟. RNA氧化在阿尔茨海默症发病中的作用机制研究[D]. 北京：北京协和医学院, 2013: 23-31.
[6] 王金春, 刘慧影, 曹云鹏. tau蛋白与阿尔茨海默症[J]. 中国组织工程研究, 2014, 6(17):
66-75.
[7] Piotr Lewczuk, Hermann Esselmann, Mirko Bibl, et al. Tau protein
phosphorylated at threonine 181 in CSF as a neurochemical biomarker in
Alzheimer's disease[J]. J Molecular Neuroscience, 2004, 23(1-2): 115-122.
[8] Tian J, Shi Jing-ying, Mann D M. Cerebral
amyloid angiopathy and dementia[J]. Brain, 2004, 8(2): 87-91.
[9] 胡钰慧, 何玲. 线粒体功能障碍与阿尔茨海默症发病的相关性研究进展[J]. 药学研究, 2020, (2): 101-104.
[10] Dennis J Selkoe. Toward a
comprehensive theory for Alzheimer's disease-Hypothesis: Alzheimer's disease is
caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein[J].
Conference on Towards A Comprehensive Theory for Alzheimers Diaease, 2017, 7(5):
43-49.
[11] 王威丽, 宋沧桑. 阿尔茨海默症发病机制的研究进展及临床用药[J]. 中国药物评价, 2019, 6(3):
204-209.
[12] Jon Toledo, Henrik Zetterberg, Argonde C Van Harten, et al. Alzheimer's
disease cerebrospinal fluid biomarker in cognitively normal subjects[J]. Brain, 2009,
7(9): 88-94.
[13] Wang Peng-cheng, Wang Qiu-hong, Yang Bing-you, et al. The progress
of metabolomics study in traditional chinese medicine research[J]. American
J Chinese Medicine, 2015, 8(4): 28-30.
[14] 常艳, 薛毅珑. 阿尔茨海默症的发病机制及其研究进展[J]. 中国组织工程研究, 2016, 8(4):
693-695.
[15] 刘佳福, 刘振国. 阿尔茨海默症炎症发病机制的研究进展[J]. 中风与神经疾病杂志, 2004, 21(5):
471-472.
[16] Fan Wu-qiang, Toshihiko Yanase, Hidetaka Morinaga, et al. Atrazine-induced
aromatase expression is SF-1 dependent: implications for endocrine disruption
in wildlife and reproductive cancers in humans[J].
Environmental Health Perspectives, 2017, 115(5):720-727.
[17] 顾亦婷, 顾海. 阿兹海默症中西医辨证治疗[J]. 辽宁中医药大学学报, 2015, 12(8):
139-141.
[18] 苗霞. 以Tau蛋白为靶标治疗阿尔茨海默症的分子设计[D]. 重庆：重庆大学, 2012:31-35.
[19] Gao Yong-lei, Wang Nan, Sun Fu-rong, et al. Tau in
neurodegenerative disease[J]. Annals of Translational Medicine, 2018, 6(10):
175-175.
[20] Claude Michel Wischik, Novak M, Thogersen H C, et al. Isolation of
a fragment of tau derived from the core of the paired helical filament of
Alzheimer disease[J]. Proceedings of the National Academy of
Sciences, 1988, 85(12): 4506-4510.
[21] 周妍妍, 杨光, 康倩倩, 等. 单味中药及有效成分对阿尔茨海默症Aβ沉积影响的实验研究进展[J]. 中国中医药现代远程教育, 2019, 17(03):127-129.
[22] Holmes C, Cunningham C, Zotova E, et al. Proinflammatory
cytokines, sickness behavior, and Alzheimer disease[J].
Neurology, 2011, 77(3): 212-218.
[23] 白淑玉. 中医对阿兹海默病的认识与辨证论治[J]. 中国医药指南, 2007, 2(S1):
45-49.
[24] Marcela Colombres, Juan Paulo Sagal, Nibaldo C
Inestrosa. An overview of the current and novel drugs for Alzheimer's
disease with particular reference to anti-cholinesterase compounds[J]. Current Pharmaceutical Design, 2018, 10(25): 3121-3130.
[25] 张春燕, 杨斌, 舒雨雁, 等. 神经生长因子偶联物对老年性痴呆动物模型的保护作用[J]. 中华生物医学工程杂志, 2004, 10(2): 85-87, 90.
[26] Kirk P Townsend, Domenico Pratico. Novel therapeutic opportunities for Alzheimer’s
disease: focus on nonsteroidal anti-inflammatory drugs[J]. J Faseb,
2015, 19(12): 1592-1601.
[27] Tortosa E, Avila J, M Pérez. Acetylsalicylic
acid decreases tau phosphorylation at serine 422[J].
Neuroence Letters, 2016, 396(1): 77-80.
[28] 朱榆红, 冯忠堂. 老年性痴呆的基因治疗与神经生长因子[J]. 中华医学研究杂志, 2015, 7(6):
34-39.
[29] 冯晓灵. 老年痴呆的病因及药物治疗现状[J]. 医学理论与实践, 2016, 29(4):
444-445,448.
[30] 付新, 常玉新, 张洋, 等. 中药治疗老年痴呆症的研究综述[J]. 中医药学报, 2016, 8(4):
130-132.
[31] 李斌, 伍文彬, 谢淑玲, 等. 黄连解毒汤对2型糖尿病大鼠学习记忆能力及脑内Alzheimer病样tau蛋白磷酸化途径的影响[J].中华中医药杂志, 2015, 30(5):1421-1425.
[32] 余世敏. 涤痰汤对Alzheimer病模型大鼠行为学及中枢胆碱能系统的影响[D].武汉：湖北中医学院, 2007: 60-65.
[33] 宋建芳, 王宏洁, 司南, 等. 黄连解毒汤的抗氧化作用及抑制乙酰胆碱酯酶活性的研究[J]. 中国实验方剂学杂志, 2010, 16(5):
61-64.
[34] 程海英, 程东旗. 针灸治疗老年性痴呆相关评价指标的研究进展[J]. 中国针灸, 2016, 26(8):
605-608.
[35] 周妍妍, 姚辛敏, 何秀丽, 等. 地黄饮子对Aβ诱导的PC12细胞SODmRNA表达影响的研究[J]. 中西医结合心脑血管病杂志, 2018, 9(6):
704-706.
[36] 郎俊. 温脾通络开窍汤辨证加减治疗老年性痴呆痰浊阻窍证临床研究[J]. 四川中医, 2015, 7(7):
83-85.
[37] Goode B L, Denis P E, Panda D, et al. Functional interactions between the proline-rich and repeat
regions of tau enhance microtubule binding and assembly[J]. Molecular Biology
of the Cell, 1997, 8(2): 353-365.
[38] Yan Jing-lai, Chen Yan-qing. Traditional
Chinese medical understanding on pathogenesis of senile dementia[J]. China J
Traditional Chinese Medicine and Pharmacy, 2018, 23(7): 640-642.
|
